| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Published online before print March 9, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1
* Center for Infectious Diseases and Departments of
Molecular Genetics and Microbiology and
Pathology, School of Medicine, Stony Brook University, New York
1Correspondence: Center for Infectious Diseases, Room 240 CMM, Stony Brook University, Stony Brook, NY 11794-5120. E-mail: Martha.Furie{at}stonybrook.edu
Francisella tularensis is the highly infectious agent of tularemia, a disease that can prove fatal in humans. An attenuated live vaccine strain (LVS) of this bacterium is avirulent in man but produces lethal illness in mice. As a step toward understanding the species specificity of the LVS, we compared its interactions with murine and human leukocytes. The bacterium replicated within murine bone marrow-derived macrophages (muBMDM), human monocyte-derived macrophages (huMDM), and freshly isolated human monocytes. However, the murine and human phagocytes differed in their ability to secrete proinflammatory cytokines in response to the LVS. The huMDM released large amounts of CXC chemokine ligand 8 (CXCL8) and CC chemokine ligand 2 when incubated with live or killed LVS organisms, and live bacteria also elicited production of interleukin-1ß (IL-1ß). Furthermore, human monocytes secreted CXCL8, IL-1ß, and tumor necrosis factor 
in response to various bacterial preparations. In contrast, muBMDM produced little to no proinflammatory cytokines or chemokines when treated with any preparations of the LVS. Clearly, human and murine macrophages support growth of this bacterium. However, the greater proinflammatory response of human leukocytes to F. tularensis LVS may contribute to the avirulence of this strain in the human host.
Key Words: bacterial infection • chemokines • inflammatory cytokines • monocytes
This article has been cited by other articles:
|
|
 |
|
  R. R. Craven, J. D. Hall, J. R. Fuller, S. Taft-Benz, and T. H. Kawula Francisella tularensis Invasion of Lung Epithelial Cells Infect. Immun., July 1, 2008; 76(7): 2833 - 2842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chiavolini, J. Alroy, C. A. King, P. Jorth, S. Weir, G. Madico, J. R. Murphy, and L. M. Wetzler Identification of Immunologic and Pathologic Parameters of Death versus Survival in Respiratory Tularemia Infect. Immun., February 1, 2008; 76(2): 486 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Lindemann, M. K. McLendon, M. A. Apicella, and B. D. Jones An In Vitro Model System Used To Study Adherence and Invasion of Francisella tularensis Live Vaccine Strain in Nonphagocytic Cells Infect. Immun., June 1, 2007; 75(6): 3178 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. ELKINS, S. C. COWLEY, and C. M. BOSIO Innate and Adaptive Immunity to Francisella Ann. N.Y. Acad. Sci., June 1, 2007; 1105(1): 284 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Butchar, M. V. S. Rajaram, L. P. Ganesan, K. V. L. Parsa, C. D. Clay, L. S. Schlesinger, and S. Tridandapani Francisella tularensis Induces IL-23 Production in Human Monocytes J. Immunol., April 1, 2007; 178(7): 4445 - 4454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Bosio, H. Bielefeldt-Ohmann, and J. T. Belisle Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu4 J. Immunol., April 1, 2007; 178(7): 4538 - 4547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Hall, R. R. Craven, J. R. Fuller, R. J. Pickles, and T. H. Kawula Francisella tularensis Replicates within Alveolar Type II Epithelial Cells In Vitro and In Vivo following Inhalation Infect. Immun., February 1, 2007; 75(2): 1034 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. S. Rajaram, L. P. Ganesan, K. V. L. Parsa, J. P. Butchar, J. S. Gunn, and S. Tridandapani Akt/Protein Kinase B Modulates Macrophage Inflammatory Response to Francisella Infection and Confers a Survival Advantage in Mice J. Immunol., November 1, 2006; 177(9): 6317 - 6324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ben Nasr, J. Haithcoat, J. E. Masterson, J. S. Gunn, T. Eaves-Pyles, and G. R. Klimpel Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria J. Leukoc. Biol., October 1, 2006; 80(4): 774 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Balagopal, A. S. MacFarlane, N. Mohapatra, S. Soni, J. S. Gunn, and L. S. Schlesinger Characterization of the Receptor-Ligand Pathways Important for Entry and Survival of Francisella tularensis in Human Macrophages Infect. Immun., September 1, 2006; 74(9): 5114 - 5125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Schulert and L.-A. H. Allen Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor J. Leukoc. Biol., September 1, 2006; 80(3): 563 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gil, G. J. Platz, C. A. Forestal, M. Monfett, C. S. Bakshi, T. J. Sellati, M. B. Furie, J. L. Benach, and D. G. Thanassi Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence PNAS, August 22, 2006; 103(34): 12897 - 12902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I Duenas, M. Aceves, A. Orduna, R. Diaz, M. Sanchez Crespo, and C. Garcia-Rodriguez Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS Int. Immunol., May 1, 2006; 18(5): 785 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Gavrilin, I. J. Bouakl, N. L. Knatz, M. D. Duncan, M. W. Hall, J. S. Gunn, and M. D. Wewers Internalization and phagosome escape required for Francisella to induce human monocyte IL-1{beta} processing and release PNAS, January 3, 2006; 103(1): 141 - 146. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
